Pulse nav.journalClub Debates activos Tendencias Explorar Preguntas Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock | Synapse

June 16, 2009

Uso temprano de hemoperfusión con polimixina B en shock séptico abdominal

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

clinicaltrials.gov Identificador: NCT00629382.

Me gusta

Guardar

Compartir

Me gusta

Guardar

Compartir

Cite This Study

Cruz et al. (Mar,) estudiaron esta cuestión.

synapsesocial.com/papers/69d842f58c03fbaff8bee869 https://doi.org/https://doi.org/10.1001/jama.2009.856

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and β-thromboglobulin1999 · 77 citations
2Randomized trials stopped early for benefit: a systematic review.2005 · 696 citations
3Noninvasive Positive-Pressure Ventilation for Respiratory Failure After Extubation2005 · 55 citations
4Hemoperfusion with Polymyxin B Immobilized Fibers for Urinary Albumin Excretion in Septic Patients with Trauma2002 · 25 citations
5Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin- resistant Staphylococcus aureus2003 · 37 citations